Viewing Study NCT00790127


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2025-12-26 @ 4:12 AM
Study NCT ID: NCT00790127
Status: COMPLETED
Last Update Posted: 2011-05-20
First Post: 2008-11-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase 1/2 Study of HQK-1001 in Patients With Beta Thalassemia
Sponsor: HemaQuest Pharmaceuticals Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module